Protocol for Comparison of Two Different Regimens of Rabbit ATG-Fresenius With Cyclosporin in the Treatment of Acquired Aplastic Anaemia
Phase of Trial: Phase IV
Latest Information Update: 05 Apr 2018
Price : $35 *
At a glance
- Drugs Antithymocyte globulin (Primary) ; Ciclosporin
- Indications Aplastic anaemia
- Focus Therapeutic Use
- 03 Apr 2016 Planned End Date changed from 1 Dec 2015 to 1 Dec 2017 as reported by ClinicalTrials.gov record.
- 03 Apr 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Dec 2017 as reported by ClinicalTrials.gov record.
- 05 Feb 2014 New trial record